The need for SPeeD: can acute surfactant protein D administration reduce ventilator-induced inflammation?
Authors:
Open Access
- 3 November 2026
- journal article
- editorial
- Published by Springer Nature in Pediatric Research
- p. 1-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A recombinant fragment of human surfactant protein D reduces lung inflammation in preterm lambsPediatric Research, 2026
- Targeting neutrophil-driven inflammation in bronchopulmonary dysplasia: From pathogenesis to therapeutic perspectivesPaediatric Respiratory Reviews, 2026
- Recombinant fragment of human surfactant protein D to prevent neonatal chronic lung disease (RESPONSE): a protocol for a phase I safety trial in a tertiary neonatal unitBMJ Open, 2024
- Surfactant as a drug carrierSeminars in Fetal and Neonatal Medicine, 2023
- Surfactant replacement therapy: from biological basis to current clinical practicePediatric Research, 2020
- SP-D attenuates LPS-induced formation of human neutrophil extracellular traps (NETs), protecting pulmonary surfactant inactivation by NETsCommunications Biology, 2019
- Gradual Aeration at Birth Is More Lung Protective Than a Sustained Inflation in Preterm LambsAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Evolution of surfactant therapy for respiratory distress syndrome: past, present, and futurePediatric Research, 2016
- Pulmonary Surfactant: An Immunological PerspectiveCellular Physiology and Biochemistry, 2010
- An overview of pulmonary surfactant in the neonate: Genetics, metabolism, and the role of surfactant in health and diseaseMolecular Genetics and Metabolism, 2009